Your SlideShare is downloading. ×
Global Medical Cures™ | Drugs approved for Non Hodgkin Lymphoma
Global Medical Cures™ | Drugs approved for Non Hodgkin Lymphoma
Global Medical Cures™ | Drugs approved for Non Hodgkin Lymphoma
Upcoming SlideShare
Loading in...5
×

Thanks for flagging this SlideShare!

Oops! An error has occurred.

×
Saving this for later? Get the SlideShare app to save on your phone or tablet. Read anywhere, anytime – even offline.
Text the download link to your phone
Standard text messaging rates apply

Global Medical Cures™ | Drugs approved for Non Hodgkin Lymphoma

307

Published on

Global Medical Cures™ | Drugs approved for Non Hodgkin Lymphoma …

Global Medical Cures™ | Drugs approved for Non Hodgkin Lymphoma


DISCLAIMER-

Global Medical Cures™ does not offer any medical advice, diagnosis, treatment or recommendations. Only your healthcare provider/physician can offer you information and recommendations for you to decide about your healthcare choices.

Published in: Health & Medicine
0 Comments
0 Likes
Statistics
Notes
  • Be the first to comment

  • Be the first to like this

No Downloads
Views
Total Views
307
On Slideshare
0
From Embeds
0
Number of Embeds
0
Actions
Shares
0
Downloads
1
Comments
0
Likes
0
Embeds 0
No embeds

Report content
Flagged as inappropriate Flag as inappropriate
Flag as inappropriate

Select your reason for flagging this presentation as inappropriate.

Cancel
No notes for slide

Transcript

  • 1. National Cancer Institute at the National Institutes of Health Updated: 03/10/2014 Drugs Approved for Non-Hodgkin Lymphoma This page lists cancer drugs approved by the Food and Drug Administration (FDA) for non-Hodgkin lymphoma. The list includes generic and brand names. This page also lists common drug combinations used in non-Hodgkin lymphoma. The individual drugs in the combinations are FDA-approved. However, drug combinations themselves usually are not approved, but are widely used. The drug names link to NCI's Cancer Drug Information summaries. There may be drugs used in non-Hodgkin lymphoma that are not listed here. Abitrexate (Methotrexate) Adcetris (Brentuximab Vedotin) Adriamycin PFS (Doxorubicin Hydrochloride) Adriamycin RDF (Doxorubicin Hydrochloride) Ambochlorin (Chlorambucil) Amboclorin (Chlorambucil) Arranon (Nelarabine) Bendamustine Hydrochloride Bexxar (Tositumomab and Iodine I 131 Tositumomab) Blenoxane (Bleomycin) Bleomycin Bortezomib Brentuximab Vedotin Chlorambucil Clafen (Cyclophosphamide) Cyclophosphamide Cytoxan (Cyclophosphamide) Denileukin Diftitox DepoCyt (Liposomal Cytarabine) Doxorubicin Hydrochloride DTIC-Dome (Dacarbazine) Folex (Methotrexate) Folex PFS (Methotrexate) Folotyn (Pralatrexate) Cancer Drug Information Drugs Approved for Non-Hodgkin Lymphoma - National Cancer Institute http://www.cancer.gov/cancertopics/druginfo/non-hodgkin/print 1 of 3 5/12/2014 3:56 AM
  • 2. Ibritumomab Tiuxetan Ibrutinib Imbruvica (Ibrutinib) Intron A (Recombinant Interferon Alfa-2b) Istodax (Romidepsin) Lenalidomide Leukeran (Chlorambucil) Linfolizin (Chlorambucil) Liposomal Cytarabine Matulane (Procarbazine Hydrochloride) Methotrexate Methotrexate LPF (Methotrexate) Mexate (Methotrexate) Mexate-AQ (Methotrexate) Mozobil (Plerixafor) Nelarabine Neosar (Cyclophosphamide) Ontak (Denileukin Diftitox) Plerixafor Pralatrexate Recombinant Interferon Alfa-2b Revlimid (Lenalidomide) Rituxan (Rituximab) Rituximab Romidepsin Tositumomab and Iodine I 131 Tositumomab Treanda (Bendamustine Hydrochloride) Velban (Vinblastine Sulfate) Velcade (Bortezomib) Velsar (Vinblastine Sulfate) Vinblastine Sulfate Vincasar PFS (Vincristine Sulfate) Vincristine Sulfate Vorinostat Zevalin (Ibritumomab Tiuxetan) Zolinza (Vorinostat) Drug Combinations Used in Non-Hodgkin Lymphoma CHOP COPP CVP EPOCH Hyper-CVAD ICE Drugs Approved for Non-Hodgkin Lymphoma - National Cancer Institute http://www.cancer.gov/cancertopics/druginfo/non-hodgkin/print 2 of 3 5/12/2014 3:56 AM
  • 3. R-CHOP Drugs Approved for Non-Hodgkin Lymphoma - National Cancer Institute http://www.cancer.gov/cancertopics/druginfo/non-hodgkin/print 3 of 3 5/12/2014 3:56 AM

×